Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aster DM Healthcare Ltd. ( (IN:ASTERDM) ) just unveiled an announcement.
Aster DM Healthcare’s Investment and Finance Committee has approved a proposal to increase its stake in its material subsidiary, Malabar Institute of Medical Sciences Ltd. (MIMS), from 79.75% to 100% by acquiring up to an additional 20.25% equity from existing shareholders for cash consideration. The move, which is not classified as a related-party transaction and requires no specific regulatory approvals, will be executed through a letter of offer expected to be dispatched shortly, with completion targeted within three months thereafter, and is aimed at fully consolidating a highly profitable hospital asset within Aster’s portfolio, potentially enhancing control, earnings consolidation and strategic flexibility for the group.
More about Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. is a healthcare services provider operating hospitals and related medical facilities, with a focus on delivering clinical care through its network of subsidiaries, including Malabar Institute of Medical Sciences Ltd. (MIMS), a material subsidiary generating over INR 1,100 crore in annual turnover and significant profitability within the Indian healthcare sector.
Average Trading Volume: 35,563
Technical Sentiment Signal: Buy
Current Market Cap: 287.7B INR
See more insights into ASTERDM stock on TipRanks’ Stock Analysis page.